CN109239253A - A kind of efficient liquid phase detection method of the impurity of Abacavir - Google Patents

A kind of efficient liquid phase detection method of the impurity of Abacavir Download PDF

Info

Publication number
CN109239253A
CN109239253A CN201811109775.7A CN201811109775A CN109239253A CN 109239253 A CN109239253 A CN 109239253A CN 201811109775 A CN201811109775 A CN 201811109775A CN 109239253 A CN109239253 A CN 109239253A
Authority
CN
China
Prior art keywords
impurity
abacavir
phase
acid solution
detection method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811109775.7A
Other languages
Chinese (zh)
Other versions
CN109239253B (en
Inventor
周洁
丁屏
陈婷婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Shyndec Pharmaceutical Co Ltd
Original Assignee
Shanghai Shyndec Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Shyndec Pharmaceutical Co Ltd filed Critical Shanghai Shyndec Pharmaceutical Co Ltd
Priority to CN201811109775.7A priority Critical patent/CN109239253B/en
Publication of CN109239253A publication Critical patent/CN109239253A/en
Application granted granted Critical
Publication of CN109239253B publication Critical patent/CN109239253B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/89Inverse chromatography

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

This application discloses a kind of efficient liquid phase detection method of the impurity of Abacavir, the structural formula of impurity isWherein, R is alkyl, alkenyl, alkynyl, aryl, hydroxyl, halogen, hydroxyalkyl, carboxyl or ester group;The described method includes: providing sample analysis solution;Sample analysis solution injection high performance liquid chromatograph is subjected to chromatography, and records chromatogram;Chromatographic column used in it is reverse-phase chromatographic column, and mobile phase used is the mixed liquor of acid solution and solvent phase.By the above-mentioned means, the application can be improved the separating degree and accuracy of detection.

Description

A kind of efficient liquid phase detection method of the impurity of Abacavir
Technical field
This application involves Pharmaceutical Analysis technical fields, detect more particularly to a kind of efficient liquid phase of the impurity of Abacavir Method.
Background technique
Abacavir (abacavir, ABC) is a kind of anti-AIDS new drug, is new carbocyclic ring 2'- deoxyguanosine ucleosides Drug, oral administration biaavailability is high, easily infiltration central nervous system.As other efabirenzs, it It is an inactive prodrug, is metabolized into active triguaiacyl phosphate through 4 steps in vivo, and pass through following 2 approach It plays the effect of HIV inhibiting (HIV) reverse transcriptase: 1. competitively inhibiting 2'- deoxyguanosine triphosphate ester (dGTP) (one of DNA synthesis segment) is combined into nucleic acid chains.2. by preventing the addition of new base from effectively terminating DNA chain Synthesis.The chemical structural formula of Abacavir is as follows:
Abacavir (Formula IV) the preparation method is as follows: anti-under alkaline condition by Formula II compound and formula III compound Formula IV should be obtained, triethyl orthoformate and acidic alcohol reaction is added, (1S, 4R) -4- is obtained after filtering, and (2- amino -6- is chloro- 9H- purine -9- base) -2- cyclopentene -1- methoxide hydrochlorate (Formula V), then react to obtain Abacavir (Formula IV) with cyclopropylamine
Present inventor is in long-term R&D process, during discovery prepares Abacavir (VI), due to chemistry The relationship for reacting balance always has a small amount of raw material to remain, is brought into subsequent reaction step, and can be with the original in subsequent reactions Material or product react, therefore generate many impurity during synthesizing Abacavir, these impurity will affect Abacavir The purity of product, and there are partial impurities to be disclosed at present, and have coherent detection control means, and there is no quilts for some impurity It is open, detection control more is carried out to these impurity without good method, therefore need a kind of scientific and effective analysis method pair Impurity carries out detection control.
Summary of the invention
The application is mainly solving the technical problems that provide a kind of efficient liquid phase detection method of the impurity of Abacavir, energy Enough separating degrees and accuracy for improving detection.
In order to solve the above technical problems, the technical solution that the application uses is: providing a kind of impurity of Abacavir Efficient liquid phase detection method, the structural formula of impurity isWherein, R is alkyl, alkenyl, alkynyl, Aryl, hydroxyl, halogen, hydroxyalkyl, carboxyl or ester group;The described method includes: providing sample analysis solution;By sample analysis solution It injects high performance liquid chromatograph and carries out chromatography, and record chromatogram;Chromatographic column used in it is reverse-phase chromatographic column, used Mobile phase be acid solution and solvent phase mixed liquor.
Wherein, solvent is mutually water-organic phase mixed liquor;Organic phase is methanol or acetonitrile.
Wherein, the volume ratio of acid solution and solvent phase is 98:2~2:98 in mobile phase;Water and organic phase in solvent phase Volume ratio is 5:95~25:75;The pH value of mobile phase is 1.0~9.0.
Wherein, eluted by the way of gradient elution, wherein when gradient elution, at runtime between 0~20 minute In range, in mobile phase the volume ratio of acid solution be 95~70%, at runtime between 20~35 minutes within the scope of, in mobile phase The volume ratio of acid solution be 70~10%, at runtime between 35~35.1 minutes within the scope of, the volume of acid solution in mobile phase Than being 10~95%, at runtime between 35.1~50 minutes within the scope of, in mobile phase the volume ratio of acid solution be 95~95%.
Wherein, acid solution is aqueous solution, and the volumetric concentration of acid solution is 0.01%-0.1%, acid solution be formic acid solution, Acetic acid solution or trifluoroacetic acid solution.
Wherein, reverse-phase chromatographic column is phenyl silane bonded silica gel chromatographic column, cyano bonded silica gel chromatographic column, amino bonded silicon Glue chromatographic column, octadecylsilane chemically bonded silica chromatographic column or eight alkyl silane bonded silica gel chromatographic columns.
Wherein, the column length of reverse-phase chromatographic column is 100mm~300mm, and internal diameter is 1mm~10mm, and partial size is 1 μm~10 μm.
Wherein, the flow velocity of mobile phase is 0.8~1.3ml/min;The column temperature of chromatographic column is 25~50 DEG C, and Detection wavelength is 205~300nm;Runing time is 30~70min.
Wherein, water, methanol, ethyl alcohol, acetonitrile, methanol-water mixture, ethanol-water mixture, acetonitrile-water mixed liquor are utilized Sample is dissolved, sample analysis solution is made.
Wherein, sample is Abacavir bulk pharmaceutical chemicals, Abacavir intermediate or Abacavir preparation.
The beneficial effect of the application is: being in contrast to the prior art, the application has found Abacavir preparation process One of new impurity, and the efficient liquid phase detection method of the impurity is provided, by utilizing reverse-phase chromatographic column, and molten using acid Liquid and the mixed solvent of solvent phase are eluted, and can be improved the detection separating degree and detection limit of impurity.
Detailed description of the invention
Fig. 1 is the mass spectrogram of the application Abacavir impurity compound;
Fig. 2 is the nucleus magnetic hydrogen spectrum figure of the application Abacavir impurity compound;
Fig. 3 is the flow diagram of the efficient liquid phase detection method first embodiment of the impurity of the application Abacavir;
Fig. 4 is the detection chromatogram of the application experimental example 1;
Fig. 5 is the detection chromatogram of the application experimental example 2;
Fig. 6 is the detection chromatogram of the application experimental example 3;
Fig. 7 is the detection chromatogram of the application experimental example 4;
Fig. 8 is the detection chromatogram of the application experimental example 5.
Specific embodiment
It is right as follows in conjunction with drawings and embodiments to keep the purpose, technical solution and effect of the application clearer, clear The application is further described.
The application provides a kind of efficient liquid phase detection method of the impurity of Abacavir, wherein Abacavir synthesis process In can generate plurality of impurities, it is specific that see Table 1 for details.Specifically, Abacavir is made usually in the following way:
Present inventor has found in the synthesis process, when remaining (1S-cis) -4- amino -2- cyclopentenyl -1- first Alcohol (II) is brought into intermediate (1S -4R) -4- (the chloro- 9H- purine -9- base of 2- amino -6-) -2- cyclopentene -1- methanolic hydrochloric acid When in salt (V), compound Formula II has similar primary amine reaction site with cyclopropylamine, therefore during synthesizing Abacavir Close object Formula II and Formula V and can react and generates impurity, confirm after nuclear-magnetism and mass spectral analysis the impurity be ((1S, 4R) -4- (2- amino -6- ((1R, 4S) -4- (methylol) cyclopenta -2- alkenyl amino) -9H- purine -9- base) cyclopenta -2- Alkenyl) methanol (I), it makes a concrete analysis of result figure and please refers to Fig. 1 and Fig. 2, Fig. 1 is the mass spectrum of the application Abacavir compound impurities Figure, wherein abscissa indicates mass-to-charge ratio (m/z) value of ion on figure;Ordinate indicates the intensity of ion stream on figure;In the application In, compound I is in mass spectroscopy, with the characteristic peak at 343.5m/z;Fig. 2 is the application Abacavir compound impurities Nucleus magnetic hydrogen spectrum figure, wherein ordinate is nuclear magnetic resonance peak signal strength on figure;Abscissa is the (resonance of resonant field intensity on figure Frequency);In this application, above compound I nuclear magnetic resonance spectroscopy (1H H NMR spectroscopy) be1H NMR (400MHz, MeOD), δ 1.45~1.73 (m, 2H), 2.60~2.80 (m, 2H), 2.81~2.88 (m, 1H), 2.90~3.09 (m, 1H), 3.57~ 3.61 (m, 2H), 3.63~3.66 (m, 2H), 5.529~5.531 (m, 1H), 5.571~5.591 (m, 1H), 5.87~5.90 (m, 1H), 5.91~5.93 (m, 1H), 5.95~5.97 (m, 1H), 6.18~6.20 (m, 1H), 7.74 (s, 1H).And the substance Compound (Formulas I) is not mentioned in passing document, and lacks corresponding analysis method, but in Abacavir actual production In again can generate, therefore, the application provides a kind of detection method for detecting this kind of impurity thing.
Table 1: the impurity title and structure of Abacavir
Referring to Fig. 3, Fig. 3 is the stream of the efficient liquid phase detection method first embodiment of the impurity of the application Abacavir Journey schematic diagram.In this embodiment, detection method includes the following steps:
S301: sample analysis solution is provided.
Wherein, when preparing sample analysis solution, it is contemplated that detection limit problem should control impurity in sample analysis solution Content in the appropriate range, as impurity content can be 0.1~10 μ g.
Wherein, the structural formula of this kind of impurity compound isWherein, R is alkyl, alkenyl, Alkynyl, aryl, hydroxyl, halogen, hydroxyalkyl, carboxyl or ester group;Specifically, compound can be
S302: sample analysis solution injection high performance liquid chromatograph is subjected to chromatography, and records chromatogram;Wherein color Spectrum column is reverse-phase chromatographic column, and mobile phase is the mixed liquor of acid solution and solvent phase.
Wherein, according to chromatographic specification requirement, testing conditions are first set, after instrument is stable, sample introduction utilizes stream Dynamic phase is eluted, and records chromatogram, is analyzed chromatogram, obtains impurity content.
In this embodiment, it by utilizing reverse-phase chromatographic column, and is carried out using acid solution and the mixed solvent of solvent phase Elution, can be improved the detection separating degree and accuracy of impurity.
Wherein, it due to containing plurality of impurities in Abacavir, may influence each other between impurity, it has been investigated that due to Impurity is intermediate polarity to differ greatly, remaining impurity does not influence the measurement of compound I (impurity M) in Abacavir, and impurity J, miscellaneous The influence that matter L measures compound in Abacavir (I), therefore while developing the detection method of compound I, study impurity J, the influence that impurity L measures compound in Abacavir (I).
Wherein, in one embodiment, reversed-phased high performace liquid chromatographic (Reversed-phase High is utilized Performance Liquid Chromatogra, RT-HPLC or RP-HPLC) it is detected, reversed-phased high performace liquid chromatographic is The liquid chromatographic system as composed by non-polar stationary phase and polarity mobile phase, this method be suitable for separation nonpolarity, polarity or from Subtype compound.Therefore chromatographic column used is reverse-phase chromatographic column, and reverse-phase chromatographic column is selected from phenyl silane bonded silica gel chromatographic column, cyanogen Base bonded silica gel chromatographic column, amino bonded silica gel chromatographic column, octadecylsilane chemically bonded silica chromatographic column or eight alkyl silane keys Close one of silica gel chromatographic column or a variety of.
The concrete specification of reverse-phase chromatographic column are as follows: column length 100mm~300mm, such as 150mm, 200mm, 250mm etc.;Internal diameter 1mm~10mm, such as 2.5mm, 5.0mm, 8.0mm etc.;1 μm~10 μm of partial size, such as 2 μm, 3 μm, 5 μm, 7 μm.Such as it can be with It is Waters symmetry C18 (3.9*150mm, 5um) octadecylsilane chemically bonded silica chromatographic column.
Mobile phase is the mixed liquor of acid solution and solvent phase, and solvent is mutually water-organic phase mixed liquor;Organic phase is methanol Or acetonitrile;Acid solution is formic acid solution, acetic acid solution or trifluoroacetic acid solution;Acid solution is aqueous solution, and the volume of acid solution is dense Spending is 0.01%-0.1%, such as 0.03%, 0.05%, 0.08%, 0.10% etc..For example, acid solution is that 0.05% volume is dense Trifluoroacetic acid-aqueous solution of degree.The pH value of mobile phase be 1.0~9.0, such as pH value be 1.5,3.5,5.5,6.0,7.5, 8.5 waiting.
Wherein, the volume ratio of acid solution and solvent phase is 98:2~2:98 in mobile phase;As 90:10,70:30,50:50, 30:70,15:85 etc..The volume ratio of water and organic phase is 5:95~25:75 in solvent phase;Such as 10:90,15:85,20:80, 25:75 etc..Such as solvent mutually can be water: methanol=15:85 mixed liquor.
Specifically, be arranged chromatographic condition, wherein the flow velocity of mobile phase be 0.8~1.3ml/min, such as 0.9ml/min, 1.0ml/min, 1.1ml/min, 1.2ml/min etc.;The column temperature of chromatographic column is 25~50 DEG C, such as 30 DEG C, 35 DEG C, 40 DEG C, 45 DEG C etc.;The Detection wavelength of detector is 205~300nm, such as 225nm, 256nm etc.;30~70min of runing time.
Wherein, in one embodiment, it is eluted using the method for gradient elution, specifically, when gradient elution, is being transported Within the scope of 0~20 minute of row time, in mobile phase the volume ratio of acid solution be 95~70%, at runtime between 20~35 points Within the scope of clock, in mobile phase the volume ratio of acid solution be 70~10%, at runtime between 35~35.1 minutes within the scope of, flowing In phase the volume ratio of acid solution be 10~95%, at runtime between 35.1~50 minutes within the scope of, acid solution in mobile phase Volume ratio is 95~95%.
Wherein, in one embodiment, it is mixed using water, methanol, ethyl alcohol, acetonitrile, methanol-water mixture, alcohol-water Sample analysis solution is made as solvent sample dissolution in liquid, acetonitrile-water mixed liquor.Specifically, this method can also be applied Impurity in detection Abacavir bulk pharmaceutical chemicals, Abacavir intermediate or Abacavir preparation, i.e., in sample analysis solution, sample Product can be Abacavir bulk pharmaceutical chemicals, intermediate or preparation, when sample difference, utilizes the dissolution sex differernce of sample, selects different Solvent go to dissolve.Wherein Abacavir preparation can be tablet, capsule, granule, eye-drops preparations, nasal formulations, suppository, Pill, ointment cream, paste, sucking preparation, spray, aerosol, gelling agent, powder, syrup, liniment, paint, painting Film, tincture, patch, oral solution, implant, film, lotion, irrigation, soft extract, plaster, distillate medicinal water, liniment.
In the following, being illustrated, being explained to the scheme of the application by several groups of specific experiment examples, but these experimental examples are only Some exemplary arrangements, should not be taken to limit scope of the present application.Wherein, the experiment side of actual conditions is not specified in experimental example Method, usually according to conventional conditions or according to the manufacturer's recommendations.Unless otherwise defined, as used herein all special Industry and scientific words are identical as meaning well-known to those skilled in the art.
Experimental example 1
(1) instrument and chromatographic condition
High performance liquid chromatograph: e2965 highly effective liquid phase chromatographic system and work station.
Chromatographic column: Thermo Syncronis C18The octadecylsilane chemically bonded silica color of (4.6mm × 250mm, 5 μm) Compose column.
Mobile phase: preparing trifluoroacetic acid-aqueous solution of 0.05% volumetric concentration, and the mixing for preparing water/methanol (15/85) is molten Liquid carries out trifluoroacetic acid-aqueous solution and water-methanol mixture to be mixed to prepare mobile phase, trifluoroacetic acid solution-in mobile phase The ratio of (water/methanol=15/85) presses 0~20min, 20~35min, 35~35.1min, 35.1~50min time point, and acid is molten Liquid volume ratio is 95~70%, 70~10%, 10~95%, 95~95% progress gradient elutions.
Testing conditions: setting flow velocity be 1.0ml/min, Detection wavelength 254nm, 30 DEG C of column temperature.
(2) experimental procedure
Prepare sample analysis solution:
The standard sample for taking the impurity J of predetermined amount, impurity L, compound I and Abacavir respectively, with methanol-water (20: 80) dissolve and dilute to obtain sample analysis solution, wherein in every 1ml sample analysis solution containing about the impurity J of 2.5 μ g, impurity L, The Abacavir of compound I and 250 μ g.
The test of sample analysis solution:
Precision measures above-mentioned 20 μ l of analytical solution, injects high performance liquid chromatograph, carries out gradient using above-mentioned mobile phase and washes It is de-, and chromatogram is recorded, specific chromatogram is shown in attached drawing 4.Fig. 4 is the detection chromatogram of the application experimental example 1, is wherein retained in figure Time (RT)=peak 26.541min is impurity J, and the peak RT=27.921min is compound I, and the peak RT=28.898min is A Baka Wei, the peak RT=31.103min are impurity L.
Impurity J, impurity L, compound I and Abacavir can be kept completely separate under this condition it can be seen from chromatogram, can Accurately measure each impurity content.
Experimental example 2
(1) instrument and chromatographic condition
High performance liquid chromatograph: e2965 highly effective liquid phase chromatographic system and work station.
Chromatographic column: the octadecylsilane chemically bonded silica chromatography of Waters symmetry C18 (3.9*150mm, 5um) Column.
Mobile phase: preparing trifluoroacetic acid-aqueous solution of 0.02% volumetric concentration, and the mixing for preparing water/methanol (15/85) is molten Liquid carries out trifluoroacetic acid-aqueous solution and water-methanol mixture to be mixed to prepare mobile phase, trifluoroacetic acid solution-in mobile phase The ratio of (water/methanol=15/85) presses 0~20min, 20~35min, 35~35.1min, 35.1~50min time point, and acid is molten Liquid volume ratio is 95~70%, 70~10%, 10~95%, 95~95% progress gradient elutions.
Testing conditions: setting flow velocity be 1.0ml/min, Detection wavelength 254nm, 30 DEG C of column temperature.
(2) experimental procedure
Prepare sample analysis solution:
The standard sample for taking the impurity J of predetermined amount, impurity L, compound I and Abacavir respectively, with methanol-water (20: 80) dissolve and dilute to obtain sample analysis solution, wherein in every 1ml sample analysis solution containing about the impurity J of 2.5 μ g, impurity L, The Abacavir of compound I and 250 μ g.
The test of sample analysis solution:
Precision measures above-mentioned 20 μ l of analytical solution, injects high performance liquid chromatograph, carries out gradient using above-mentioned mobile phase and washes It is de-, and chromatogram is recorded, specific chromatogram is shown in attached drawing 5.Fig. 5 is the detection chromatogram of the application experimental example 2, is wherein retained in figure Time (RT)=peak 25.729min is impurity J, and the peak RT=27.036min is compound I, and the peak RT=27.767min is A Baka Wei, the peak RT=29.739min are impurity L.
Impurity J, impurity L, compound I and Abacavir can be kept completely separate under this condition it can be seen from chromatogram, can Accurately measure each impurity content.
Experimental example 3
(1) instrument and chromatographic condition
High performance liquid chromatograph: e2965 highly effective liquid phase chromatographic system and work station.
Chromatographic column: the octadecylsilane chemically bonded silica chromatography of Waters symmetry C18 (3.9*150mm, 5um) Column.
Mobile phase: preparing trifluoroacetic acid-aqueous solution of 0.05% volumetric concentration, and the mixing for preparing water/methanol (15/85) is molten Liquid carries out trifluoroacetic acid-aqueous solution and water-methanol mixture to be mixed to prepare mobile phase, trifluoroacetic acid solution-in mobile phase The ratio of (water/methanol=15/85) presses 0~20min, 20~35min, 35~35.1min, 35.1~50min time point, and acid is molten Liquid volume ratio is 95~70%, 70~10%, 10~95%, 95~95% progress gradient elutions.
Testing conditions: setting flow velocity be 1.0ml/min, Detection wavelength 254nm, 30 DEG C of column temperature.
(2) experimental procedure
Prepare sample analysis solution:
The standard sample for taking the impurity J of predetermined amount, impurity L, compound I and Abacavir respectively, with methanol-water (20: 80) dissolve and dilute to obtain sample analysis solution, wherein in every 1ml sample analysis solution containing about the impurity J of 2.5 μ g, impurity L, The Abacavir of compound I and 250 μ g.
The test of sample analysis solution:
Precision measures above-mentioned 20 μ l of analytical solution, injects high performance liquid chromatograph, carries out gradient using above-mentioned mobile phase and washes It is de-, and chromatogram is recorded, specific chromatogram is shown in attached drawing 6.Fig. 6 is the detection chromatogram of the application experimental example 3, is wherein retained in figure Time (RT)=peak 26.717min is impurity J, and the peak RT=28.013min is compound I, and the peak RT=29.022min is A Baka Wei, the peak RT=31.033min are impurity L.
Impurity J, impurity L, compound I and Abacavir can be kept completely separate under this condition it can be seen from chromatogram, can Accurately measure each impurity content.
Experimental example 4
(1) instrument and chromatographic condition
High performance liquid chromatograph: e2965 highly effective liquid phase chromatographic system and work station.
Chromatographic column: the octadecylsilane chemically bonded silica chromatography of Waters symmetry C18 (3.9*150mm, 5um) Column.
Mobile phase: preparing trifluoroacetic acid-aqueous solution of 0.05% volumetric concentration, and the mixing for preparing water/acetonitrile (15/85) is molten Liquid carries out trifluoroacetic acid-aqueous solution and water-acetonitrile mixture to be mixed to prepare mobile phase, trifluoroacetic acid solution-in mobile phase The ratio of (water/acetonitrile=15/85) presses 0~20min, 20~35min, 35~35.1min, 35.1~50min time point, and acid is molten Liquid volume ratio is 95~70%, 70~10%, 10~95%, 95~95% progress gradient elutions.
Testing conditions: setting flow velocity be 1.0ml/min, Detection wavelength 254nm, 30 DEG C of column temperature.
(2) experimental procedure
Prepare sample analysis solution:
The standard sample for taking the impurity J of predetermined amount, impurity L, compound I and Abacavir respectively, with methanol-water (20: 80) dissolve and dilute to obtain sample analysis solution, wherein in every 1ml sample analysis solution containing about the impurity J of 2.5 μ g, impurity L, The Abacavir of compound I and 250 μ g.
The test of sample analysis solution:
Precision measures above-mentioned 20 μ l of analytical solution, injects high performance liquid chromatograph, carries out gradient using above-mentioned mobile phase and washes It is de-, and chromatogram is recorded, specific chromatogram is shown in attached drawing 7.Fig. 7 is the detection chromatogram of the application experimental example 4, is wherein retained in figure Time (RT)=peak 27.946min is impurity J, and the peak RT=29.372min is compound I, and the peak RT=30.422min is A Baka Wei, the peak RT=32.645min are impurity L.
Impurity J, impurity L, compound I and Abacavir can be kept completely separate under this condition it can be seen from chromatogram, can Accurately measure each impurity content.
Experimental example 5
(1) instrument and chromatographic condition
High performance liquid chromatograph: e2965 highly effective liquid phase chromatographic system and work station.
Chromatographic column: the octadecylsilane chemically bonded silica chromatography of Waters symmetry C18 (3.9*150mm, 5um) Column.
Mobile phase: preparing trifluoroacetic acid-aqueous solution of 0.05% volumetric concentration, and the mixing for preparing water/methanol (15/85) is molten Liquid carries out trifluoroacetic acid-aqueous solution and water-methanol mixture to be mixed to prepare mobile phase, trifluoroacetic acid solution-in mobile phase The ratio of (water/methanol=15/85) presses 0~20min, 20~35min, 35~35.1min, 35.1~50min time point, and acid is molten Liquid volume ratio is 95~70%, 70~10%, 10~95%, 95~95% progress gradient elutions.
Testing conditions: setting flow velocity be 1.0ml/min, Detection wavelength 254nm, 30 DEG C of column temperature.
(2) experimental procedure
Prepare sample analysis solution:
The standard sample for taking the impurity J of predetermined amount, impurity L, compound I and Abacavir respectively, with methanol-water (20: 80) dissolve and dilute to obtain sample analysis solution, wherein in every 1ml sample analysis solution containing about the impurity J of 2.5 μ g, impurity L, The Abacavir of compound I and 250 μ g.
The test of sample analysis solution:
Precision measures above-mentioned 20 μ l of analytical solution, injects high performance liquid chromatograph, carries out gradient using above-mentioned mobile phase and washes It is de-, and chromatogram is recorded, specific chromatogram is shown in attached drawing 8.Fig. 8 is the detection chromatogram of the application experimental example 5, is wherein retained in figure Time (RT)=peak 28.462min is impurity J, and the peak RT=29.965min is compound I, and the peak RT=31.030min is A Baka Wei, the peak RT=33.422min are impurity L.
Impurity J, impurity L, compound I and Abacavir can be kept completely separate under this condition it can be seen from chromatogram, can Accurately measure each impurity content.
Above scheme, it was found that the new impurity of one of Abacavir preparation process, and provide the efficient liquid of the impurity Phase detection method by utilizing reverse-phase chromatographic column, and is eluted using acid solution and the mixed solvent of solvent phase, be can be improved The detection separating degree and detection limit of impurity.
The foregoing is merely presently filed embodiments, are not intended to limit the scope of the patents of the application, all to utilize this Equivalent structure or equivalent flow shift made by application specification and accompanying drawing content, it is relevant to be applied directly or indirectly in other Technical field similarly includes in the scope of patent protection of the application.

Claims (10)

1. a kind of efficient liquid phase detection method of the impurity of Abacavir, which is characterized in that the structural formula of the impurity isWherein, R is alkyl, alkenyl, alkynyl, aryl, hydroxyl, halogen, hydroxyalkyl, carboxyl or ester group; The described method includes:
Sample analysis solution is provided;
Sample analysis solution injection high performance liquid chromatograph is subjected to chromatography, and records chromatogram;Used in it Chromatographic column is reverse-phase chromatographic column, and mobile phase used is the mixed liquor of acid solution and solvent phase.
2. the efficient liquid phase detection method of the impurity of Abacavir according to claim 1, which is characterized in that the solvent Xiang Weishui-organic phase mixed liquor;The organic phase is methanol or acetonitrile.
3. the efficient liquid phase detection method of the impurity of Abacavir according to claim 2, which is characterized in that the flowing The volume ratio of acid solution and solvent phase is 98:2~2:98 in phase;In the solvent phase volume ratio of water and organic phase be 5:95~ 25:75;The pH value of the mobile phase is 1.0~9.0.
4. the efficient liquid phase detection method of the impurity of Abacavir according to claim 1, which is characterized in that use gradient The mode of elution is eluted, wherein when gradient elution, at runtime between 0~20 minute within the scope of, it is sour in the mobile phase The volume ratio of solution be 95~70%, at runtime between 20~35 minutes within the scope of, the volume of acid solution in the mobile phase Than being 70~10%, at runtime between 35~35.1 minutes within the scope of, in the mobile phase volume ratio of acid solution be 10~ 95%, at runtime between 35.1~50 minutes within the scope of, in the mobile phase volume ratio of acid solution be 95~95%.
5. the efficient liquid phase detection method of the impurity of Abacavir according to claim 1, which is characterized in that the acid is molten Liquid is aqueous solution, and the volumetric concentration of the acid solution is 0.01%-0.1%, the acid solution be formic acid solution, acetic acid solution or Trifluoroacetic acid solution.
6. the efficient liquid phase detection method of the impurity of Abacavir according to claim 1, which is characterized in that reverse-phase chromatography Column is phenyl silane bonded silica gel chromatographic column, cyano bonded silica gel chromatographic column, amino bonded silica gel chromatographic column, octadecylsilane Bonded silica gel chromatographic column or eight alkyl silane bonded silica gel chromatographic columns.
7. the efficient liquid phase detection method of the impurity of Abacavir according to claim 1, which is characterized in that the reverse phase The column length of chromatographic column is 100mm~300mm, and internal diameter is 1mm~10mm, and partial size is 1 μm~10 μm.
8. the efficient liquid phase detection method of the impurity of Abacavir according to claim 1, which is characterized in that mobile phase Flow velocity is 0.8~1.3ml/min;The column temperature of chromatographic column is 25~50 DEG C, and Detection wavelength is 205~300nm;Runing time is 30 ~70min.
9. the efficient liquid phase detection method of the impurity of Abacavir according to claim 1, which is characterized in that the offer Sample analysis solution includes: mixed using water, methanol, ethyl alcohol, acetonitrile, methanol-water mixture, ethanol-water mixture, acetonitrile-water It closes liquid to dissolve sample, the sample analysis solution is made.
10. the efficient liquid phase detection method of the impurity of Abacavir according to claim 9, which is characterized in that the sample Product are Abacavir bulk pharmaceutical chemicals, Abacavir intermediate or Abacavir preparation.
CN201811109775.7A 2018-09-21 2018-09-21 High performance liquid detection method for impurities of abacavir Active CN109239253B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811109775.7A CN109239253B (en) 2018-09-21 2018-09-21 High performance liquid detection method for impurities of abacavir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811109775.7A CN109239253B (en) 2018-09-21 2018-09-21 High performance liquid detection method for impurities of abacavir

Publications (2)

Publication Number Publication Date
CN109239253A true CN109239253A (en) 2019-01-18
CN109239253B CN109239253B (en) 2021-07-09

Family

ID=65056642

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811109775.7A Active CN109239253B (en) 2018-09-21 2018-09-21 High performance liquid detection method for impurities of abacavir

Country Status (1)

Country Link
CN (1) CN109239253B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112129878A (en) * 2020-10-16 2020-12-25 苏州新药篮生物医药科技有限公司 Analysis method of medical organic intermediate impurities
CN116298027A (en) * 2022-12-28 2023-06-23 江苏诺泰澳赛诺生物制药股份有限公司 Liquid chromatography detection method and application of genotoxic impurities

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0921114A1 (en) * 1989-12-22 1999-06-09 The Wellcome Foundation Limited Intermediates to therapeutic nucleosides
CN101522680A (en) * 2006-09-28 2009-09-02 埃斯特维化学股份有限公司 Process for the preparation of abacavir
CN101563346A (en) * 2006-12-21 2009-10-21 埃斯特维化学股份有限公司 Process for the preparation of abacavir
CN107383010A (en) * 2017-08-18 2017-11-24 上海现代制药海门有限公司 A kind of compound and preparation method thereof
CN107641122A (en) * 2017-08-18 2018-01-30 上海现代制药海门有限公司 A kind of Abacavir intermediate and its purification process
WO2018045150A1 (en) * 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0921114A1 (en) * 1989-12-22 1999-06-09 The Wellcome Foundation Limited Intermediates to therapeutic nucleosides
CN101522680A (en) * 2006-09-28 2009-09-02 埃斯特维化学股份有限公司 Process for the preparation of abacavir
CN101563346A (en) * 2006-12-21 2009-10-21 埃斯特维化学股份有限公司 Process for the preparation of abacavir
WO2018045150A1 (en) * 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
CN107383010A (en) * 2017-08-18 2017-11-24 上海现代制药海门有限公司 A kind of compound and preparation method thereof
CN107641122A (en) * 2017-08-18 2018-01-30 上海现代制药海门有限公司 A kind of Abacavir intermediate and its purification process

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANUJ PRAKASH ET AL: "Forced degradation study of abacavir sulfate under the frame of genotoxic impurity", 《INDIAN JOURNAL OF CHEMISTRY》 *
R. NAGESWARA RAO ET AL: "Separation and characterization of forced degradation products of abacavir sulphate by LC–MS/MS", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 *
U. SESHACHALAM ET AL: "Development and validation of a reverse-phase liquid chromatographic method for assay and related substances of abacavir sulfate", 《JOURNAL OF SEPARATION SCIENCE》 *
杨兴明: "HPLC法测定阿巴卡韦双夫定片中的含量", 《中国药师》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112129878A (en) * 2020-10-16 2020-12-25 苏州新药篮生物医药科技有限公司 Analysis method of medical organic intermediate impurities
CN116298027A (en) * 2022-12-28 2023-06-23 江苏诺泰澳赛诺生物制药股份有限公司 Liquid chromatography detection method and application of genotoxic impurities

Also Published As

Publication number Publication date
CN109239253B (en) 2021-07-09

Similar Documents

Publication Publication Date Title
CN104634887B (en) A method of separation and measurement ticagrelor and its optical isomer
CN107064350B (en) Method for detecting suspected genotoxic impurity of tofacitinib citrate
CN110487918A (en) The analysis method of genotoxicity impurity in Pantoprazole Sodium and its starting material
CN109239253A (en) A kind of efficient liquid phase detection method of the impurity of Abacavir
Zhang et al. Isolation, identification and characterization of novel process-related impurities in flupirtine maleate
CN106153798B (en) It is a kind of to be used to analyze the purposes for doing reference standard about the HPLC methods and these impurity of material for Buddhist nun's preparation according to Shandong for Buddhist nun and according to Shandong
CN102272108A (en) Hplc method for the analysis of bosentan and related substances and use of these substances as reference standards and markers
Feng et al. An efficient and target-oriented sample enrichment method for preparative separation of minor alkaloids by pH-zone-refining counter-current chromatography
Chen et al. Simultaneous determination of the content of isoquinoline alkaloids in Dicranostigma leptopodum (Maxim) Fedde and the effective fractionation of the alkaloids by high‐performance liquid chromatography with diode array detection
Nagpal et al. A review on need and importance of impurity profiling
CN103864646B (en) The impurity preparation of rasagiline mesilate and the method for analysis
CN109900830A (en) Using the method and application of sulfonamides impurity in HPLC separation determination celecoxib
CN106706796B (en) The method for detecting bortezomib key intermediate 1R- trifluoroacetate optical isomer by high performance liquid chromatography
CN106841415B (en) Analysis method in relation to substance in a kind of Azilsartan raw material and its preparation
EP2205966A2 (en) Novel chromatography methods
CN106153797B (en) It is a kind of to replace Buddhist nun's preparation Related substance method according to Shandong for Buddhist nun and according to Shandong
CN109251161B (en) Preparation method of 2-tryptophan bisulfite
CN112986432B (en) Detection method and application of 2, 4-diamino-6-chloropyrimidine related substance
Jadhav et al. Stress degradation behavior of paliperidone, an antipsychotic drug, and development of suitable stability-indicating RP-LC method
CN106908524B (en) Separation and determination method of calcipotriol intermediate L and potential genotoxic impurities thereof
Bharathi et al. Identification, isolation and characterization of potential degradation product in risperidone tablets
CN107870217A (en) Detection method of the eltrombopag olamine intermediate about material and the impurity reference substance for this method
CN110873767B (en) Rapid detection method for dexlansoprazole synthetic intermediate and related substances thereof
CN109212068A (en) A kind of efficient liquid phase detection method of the genotoxicity impurity of Zidovudine
CN106153772B (en) A method of with the related substance of the miscellaneous Shandong amine of high performance liquid chromatography detection grace

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: No.1, Linjiang Avenue, Linjiang Town, Haimen District, Nantong City, Jiangsu Province, 226000

Applicant after: Jiangsu Weiqida Pharmaceutical Co., Ltd

Address before: 226000, Linjiang Avenue, Linjiang Town, Haimen, Jiangsu, Nantong 1, China

Applicant before: SHANGHAI SHYNDEC PHARMACEUTICAL Co.,Ltd.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Zhou Jie

Inventor after: Ding Ping

Inventor after: Chen Tingting

Inventor after: Sui Dianxu

Inventor after: Mao Xiaona

Inventor after: Chen Ye

Inventor before: Zhou Jie

Inventor before: Ding Ping

Inventor before: Chen Tingting

CB03 Change of inventor or designer information